Vericel Corp (VCEL)
56.71
-0.55
(-0.96%)
USD |
NASDAQ |
Nov 21, 16:00
56.72
+0.01
(+0.02%)
After-Hours: 20:00
Vericel Profit Margin (Quarterly): -1.56% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -1.56% |
| June 30, 2024 | -8.89% |
| March 31, 2024 | -7.53% |
| December 31, 2023 | 19.99% |
| September 30, 2023 | -8.03% |
| June 30, 2023 | -10.93% |
| March 31, 2023 | -18.27% |
| December 31, 2022 | 11.24% |
| September 30, 2022 | -17.06% |
| June 30, 2022 | -24.19% |
| March 31, 2022 | -19.66% |
| December 31, 2021 | 9.53% |
| September 30, 2021 | -14.29% |
| June 30, 2021 | -9.58% |
| March 31, 2021 | -9.51% |
| December 31, 2020 | 27.02% |
| September 30, 2020 | 11.22% |
| June 30, 2020 | -41.32% |
| March 31, 2020 | -17.64% |
| December 31, 2019 | 24.12% |
| September 30, 2019 | 11.38% |
| June 30, 2019 | -75.68% |
| March 31, 2019 | -13.04% |
| December 31, 2018 | 16.73% |
| September 30, 2018 | -4.75% |
| Date | Value |
|---|---|
| June 30, 2018 | -24.46% |
| March 31, 2018 | -42.49% |
| December 31, 2017 | 1.23% |
| September 30, 2017 | -37.92% |
| June 30, 2017 | -14.09% |
| March 31, 2017 | -104.5% |
| December 31, 2016 | -37.51% |
| September 30, 2016 | -61.08% |
| June 30, 2016 | -23.74% |
| March 31, 2016 | -25.87% |
| December 31, 2015 | -31.84% |
| September 30, 2015 | -39.05% |
| June 30, 2015 | -15.84% |
| March 31, 2015 | -44.82% |
| December 31, 2014 | -16.12% |
| September 30, 2014 | -71.62% |
| June 30, 2014 | -104.6% |
| March 31, 2014 | |
| December 31, 2013 | -36.45K% |
| September 30, 2013 | |
| June 30, 2013 | -163.0K% |
| March 31, 2013 | -69.30K% |
| December 31, 2012 | -35.00K% |
| September 30, 2012 | |
| June 30, 2012 |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-41.32%
Minimum
Jun 2020
27.02%
Maximum
Dec 2020
-5.27%
Average
-9.20%
Median
Profit Margin (Quarterly) Benchmarks
| Catalyst Pharmaceuticals Inc | 34.10% |
| Exelixis Inc | 21.87% |
| Halozyme Therapeutics Inc | 47.23% |
| ADMA Biologics Inc | 29.96% |
| Natera Inc | -7.18% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 1.52% |
| Return on Assets | 0.99% |
| Return on Invested Capital | 1.52% |
| Gross Profit Margin (Quarterly) | 71.93% |
| Operating Margin (Quarterly) | -4.26% |
| Return on Net Operating Assets | 1.77% |